WebApr 12, 2024 · To see how CRISPR Therapeutics AG stock has been performing today in comparison to its peers in the industry, here are the numbers: CRSP stock’s performance was -1.40% at last check in today’s session, and -27.34% in the past year, while Pieris Pharmaceuticals Inc. (PIRS) has been trading -0.88% in recent session and positioned … Web1 day ago · The CRISPR technology market size is forecasted to increase by USD 2.88 billion from 2024 to 2026, at a CAGR of 19.34%, according to a recent market study by Technavio. The growth of the market ...
CRISPR Therapeutics (CRSP) stock forecast for 2026
WebJul 17, 2024 · Five years from now, CRISPR Therapeutics ( CRSP 1.34%) may well be a household name as a result of awe-inspiring early results … WebApr 6, 2024 · What are analysts forecasts for CRISPR Therapeutics stock? The 50 analysts offering price forecasts for CRISPR Therapeutics have a median target of 97.44, with a high estimate of 172.00 and a low ... jem star
CRISPR Therapeutics - CRSP Stock Forecast, Price & News - MarketBeat
WebStock Price Forecast. The 26 analysts offering 12-month price forecasts for CRISPR Therapeutics AG have a median target of 72.50, with a high estimate of 220.00 and a … Web4 hours ago · This company is expected to post quarterly loss of $1.67 per share in its upcoming report, which represents a year-over-year change of +28%. Revenues are expected to be $37.61 million, up 3901.5% ... WebCRSP Stock 12 Months Forecast. Based on 17 Wall Street analysts offering 12 month price targets for Crispr Therapeutics AG in the last 3 months. The average price target is $77.69 with a high forecast of $143.00 and a low forecast of $39.00. The average price target represents a 71.12% change from the last price of $45.40. jem stack game